Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

10.3K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Autophagy Modulators that Increase I1061T NPC1 Expression and Promote Cholesterol Efflux in Niemann-Pick Type C Patient-Derived Fibroblasts.

ACS chemical biology·2026
Same author

Optimization of systemic AAV9 gene therapy in Niemann-Pick disease, type C1 mice.

Life science alliance·2026
Same author

Unveiling Lipid Dysregulation: Lipidomics of Mouse Brain and Isolated Myelin in Niemann-Pick Disease Type C1.

bioRxiv : the preprint server for biology·2026
Same author

Multiomic Analysis Reveals Molecular Pathways Associated with Intestinal Aggregation of α-Synuclein.

ACS chemical biology·2026
Same author

Altered Cerebrospinal Fluid Proteins in Smith-Lemli-Opitz Syndrome.

Journal of proteome research·2025
Same author

Variation in human gut microbiota impacts tamoxifen pharmacokinetics.

mBio·2024

Related Experiment Video

Updated: May 8, 2026

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.6K

Multiomic Analysis Reveals Molecular Pathways Associated with Intestinal Aggregation of α-Synuclein.

Julia M Balsamo1, Ying Yan2, Dylan Thai1

  • 1Department of Chemistry, University of California, Irvine, CA 92617, USA.

Biorxiv : the Preprint Server for Biology
|September 5, 2025
PubMed
Summary

Parkinson's disease may start in the gut. Nitrite exposure triggers alpha-synuclein aggregation in gut cells via dopamine, but benserazide may prevent this, offering a potential therapeutic target.

Keywords:
Parkinson’s diseaseROSdopamineenteroendocrine cellsgut microbiomenitriteα-synuclein

More Related Videos

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Related Experiment Videos

Last Updated: May 8, 2026

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.6K
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

2.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Cell Biology

Background:

  • Parkinson's disease (PD) is linked to alpha-synuclein (α-synuclein) aggregation.
  • Enteroendocrine cells in the gut express α-synuclein and connect to the brain via the vagus nerve.
  • Gut microbiota metabolites, like nitrite, can induce α-synuclein aggregation in these cells.

Purpose of the Study:

  • To investigate the role of dopamine in nitrite-induced α-synuclein aggregation in enteroendocrine cells.
  • To explore the cellular and proteomic changes associated with dopamine production and α-synuclein aggregation.
  • To identify potential therapeutic strategies targeting gut-based α-synuclein formation.

Main Methods:

  • Modulation of dopamine biosynthesis in enteroendocrine cells.
  • Proteomic and lipidomic profiling of cells with varying dopamine levels.
  • Assessment of cell viability under stress conditions (nitrite, α-synuclein aggregates).
  • Testing the effect of benserazide, a dopamine synthesis inhibitor.

Main Results:

  • Dopamine production is critical for nitrite-induced α-synuclein aggregation.
  • Proteomic profiles differ significantly between dopamine-producing and dopamine-deficient cells.
  • Enteroendocrine cells remain viable despite nitrite exposure and α-synuclein aggregates, suggesting a reservoir role.
  • Benserazide inhibits α-synuclein aggregate formation in enteroendocrine cells.

Conclusions:

  • Dopamine-producing enteroendocrine cells may act as a reservoir for α-synuclein aggregates, facilitating gut-to-brain spread.
  • Inhibition of dopamine biosynthesis, using agents like benserazide, shows promise in preventing α-synuclein aggregation in the gut.
  • These findings provide a mechanistic basis for developing therapies to prevent PD progression originating from the intestine.